India Epigenetics Market (2025-2030)
The India Epigenetics Market was valued at $48.9 Million in 2025 and projected to reach to $95.1 Million by 2030, representing a compound annual growth rate of 14.2%. India's epigenetics market is poised for substantial growth as the country strengthens its position in precision medicine and genomic research.
India Epigenetics Market Trends and Insights
- India is emerging as a significant hub for epigenetic research and diagnostics within the Asia Pacific region, driven by increasing healthcare investments, rising prevalence of chronic diseases, and growing adoption of precision medicine.
- The expansion reflects India's strengthening biotechnology infrastructure and rising demand for advanced diagnostic solutions across oncology, cardiovascular, and metabolic disorders. India's epigenetics market growth is supported by expanding pharmaceutical and diagnostic sectors, coupled with government initiatives promoting genomic research and personalized medicine.
- By 2030, India is expected to capture a larger share of regional epigenetics applications, particularly in cancer diagnostics and therapeutic development.
- The market's trajectory underscores India's potential as a key player in global epigenetic innovation and clinical implementation..
Key Market Statistics
- CAGR (2025-2030) 14.2% CAGR
- Market Size, 2025 ~USD 48.9 Million
- Forecast, 2030 ~USD 95.1 Million
- Country India
India Epigenetics Market Overview
Rapid Market Expansion :
India's epigenetics market is projected to grow from $48.9 million in 2025 to $95.1 million by 2030, demonstrating a strong 14.2% CAGR, outpacing the global growth rate of 13.9%.
Asia Pacific Leadership :
India is establishing itself as a key epigenetic research and diagnostics hub within the Asia Pacific region, attracting significant investments and talent in genomic research and personalized medicine.
Healthcare Investment Surge :
Increasing government and private sector healthcare investments in India are accelerating the adoption of epigenetic technologies, diagnostic tools, and research infrastructure across major metropolitan centers.
Chronic Disease Burden :
Rising prevalence of chronic diseases including diabetes, cardiovascular disorders, and cancer in India is driving demand for epigenetic biomarkers and precision medicine solutions for early detection and treatment.
India Epigenetics Market Dynamics
- The convergence of increasing healthcare expenditure, growing awareness of epigenetic applications in disease management, and expanding research collaborations with global institutions is creating favorable conditions for market expansion.
- Government initiatives supporting biotechnology and personalized medicine are further catalyzing adoption across diagnostic centers and research institutions. The Indian epigenetics sector is expected to benefit from rising chronic disease prevalence, a large patient population, and cost-effective research capabilities.
- Emerging biotech companies and academic institutions are developing indigenous epigenetic solutions tailored to Indian populations.
- Strategic partnerships with international players and investments in genomic infrastructure will continue to drive innovation and market penetration through 2030..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Qiagen N.V.
- Agilent Technologies, Inc.
- Danaher Corporation
Key Takeaways
- India's epigenetics market is valued at $48.9 million in 2025 and is forecast to double to $95.1 million by 2030.
- India is experiencing a 14.2% CAGR, outpacing global growth and establishing itself as a regional epigenetics leader.
- India's market expansion is driven by rising chronic disease prevalence, precision medicine adoption, and biotechnology sector growth.
- By 2030, India is positioned to become a major hub for epigenetic diagnostics and therapeutic applications in Asia Pacific.
Epigenetics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | HISTONES (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 13.9% from 2025 to 2030 |
| Largest Segment | KITS & REAGENTS (Offering) |
| Market Size Base Year (Billions) | ~USD 2.24 (2025) |
| Revenue Forecast (Billions) | ~USD 4.29 (2030) |
| Segments Covered | Offering, Type, Technology, Method, Application, End User |
India Epigenetics Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Enzymes
- Instruments & Accessories
- Kits & Reagents
- Product
- Products
- Services
- Software
By Type
- 5-Hmc & 5-Mc Analysis Kits & Reagents
- Antibodies
- Bisulfite Conversion Kits & Reagents
- Chip-Sequencing Kits & Reagents
- Dna-Modifying Enzymes
- Enzymes
- Histones
- Instruments & Accessories
- Kits & Reagents
- Other Enzymes
- Other Kits & Reagents
- Protein-Modifying Enzymes
- Services
- Software
- Whole-Genome Amplification Kits & Reagents
By Technology
- Mass Spectrometry
- Next-Generation Sequencing (Ngs)
- Ngs
- Other Techniques
- Other Technologies
- Pcr & Qpcr
- Sonication
By Method
- Dna Methylation
- Histone Modifications
- Other Methods
By Application
- Cardiovascular Diseases
- Developmental Biology
- Immunology
- Metabolic Diseases
- Oncology
- Other Applications
By End User
- Academic & Research Institutes
- Contract Research Organization
- Contract Research Organizations
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
Target Audience
- Pharmaceutical & Biotech Companies : Need India market intelligence to evaluate epigenetics-based drug development opportunities, diagnostic partnerships, and commercial expansion strategies in a high-growth emerging market.
- Diagnostic & Research Laboratories : Require market data to assess demand for epigenetic testing services, benchmark competitive positioning, and plan infrastructure investments in India's expanding precision medicine sector.
- Healthcare Investors & PE Firms : Seek India-specific market sizing and growth projections to identify investment opportunities in epigenetics startups, diagnostic platforms, and research institutions with strong growth potential.
- Government & Policy Makers : Need market insights to inform healthcare policy, biotechnology funding decisions, and regulatory frameworks supporting epigenetics research and personalized medicine adoption in India.
- Academic & Research Institutions : Require market data to justify research funding proposals, identify collaboration opportunities with industry, and understand commercialization potential for epigenetic discoveries in the Indian context.
Key Companies in the India Epigenetics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| APEX BIOTECHNOLOGY CORP. | Taiwan | Public Company | Blood glucose monitoring systems (meters and strips),Other biosensor-based analyte systems (uric acid, cholesterol, lactate, HbA1c, ketone, coagulation, multifunction),Pesticide residue check systems, |
| BIOGEN | United States | Public Company | Multiple Sclerosis therapies (TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, OCREVUS economics),Spinal muscular atrophy and rare neuromuscular (SPINRAZA, QALSODY),Alzheimer’s and neurodegeneration (LEQEMBI, related), |
| EPIZYME | United States | Private Company | Tazemetostat – approved indications (epithelioid sarcoma, select lymphomas),Tazemetostat – pipeline/label-expansion use (INI1-negative tumors, combinations),Other pipeline (PRMT5 inhibitor, PRMT1 inhibitor, PARP-combination programs), |
| SIGMA-ALDRICH CORPORATION | United States | Private Company | Life science reagents and biochemicals,Cell culture media and pharma/biopharma manufacturing consumables,Analytical chemistry, filtration, and labware, |
| TRANSGENOMIC, INC. | United States | Public Company | Oncology and pharmacogenomics testing services,Multiplexed ICE COLD-PCR reagents,Other genomic testing and research services, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Life Sciences Solutions,Analytical Instruments,Specialty Diagnostics, |
| ILLUMINA, INC. | United States | Public Company | Sequencing instruments,Sequencing consumables (reagents, flow cells, library prep),Array-based instruments and consumables, |
| MERCK KGAA | Germany | Public Company | Life Science (research reagents, lab consumables, bioprocessing and CDMO services),Electronics (semiconductor materials, specialty gases, delivery equipment, display and OLED materials),Healthcare (oncology, neurology, immunology, fertility, rare disease therapies), |
| PACBIO | United States | Public Company | Long-read sequencing instruments (Revio, Sequel, Vega),Long-read consumables and SMRT reagents,Short-read sequencing (Onso) and related consumables, |
| DANAHER | United States | Public Company | Biotechnology (bioprocessing and related solutions),Life Sciences (instruments, genomics, and analytical tools),Diagnostics (clinical instruments and consumables), |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Clinical Diagnostics systems, kits, and quality controls,Life Science instruments and systems,Life Science reagents and consumables, |
| QIAGEN | Netherlands | Public Company | Sample technology consumables and instruments,Immune response and infectious disease assays,Oncology and sexual & reproductive health assays, |
| REVVITY | United States | Public Company | Diagnostics instruments, reagents, and assay platforms,Life science reagents, antibodies, and genomic tools,Instruments, imaging, software, and services, |
| HOLOGIC, INC. | United States | Private Company | Diagnostics (Aptima, Panther, ThinPrep, virology, vaginitis, SARS-CoV-2),Breast Health (3D mammography, biopsy, markers, localization, software, service),GYN Surgical (MyoSure, NovaSure, Fluent, Acessa ProVu, CoolSeal), |
APEX BIOTECHNOLOGY CORP.
APEX Biotechnology Corp. is a public company based in Taiwan that was founded in 1997.
BIOGEN
BIOGEN is a United States-based public biotechnology company founded in 1978 with 7,500 employees.
EPIZYME
EPIZYME is a United States-based private company founded in 2007 with 250 employees.
SIGMA-ALDRICH CORPORATION
SIGMA-ALDRICH CORPORATION is a United States-based private company founded in 1951 with 9,800 employees.
TRANSGENOMIC, INC.
TRANSGENOMIC, INC. is a United States-based public company founded in 1997 with 19 employees.
THERMO FISHER SCIENTIFIC INC.
THERMO FISHER SCIENTIFIC INC. is a United States-based public company founded in 1956 with 125,000 employees.
ILLUMINA, INC.
ILLUMINA, INC. is a United States-based public company founded in 1998 with 8,625 employees.
MERCK KGAA
MERCK KGAA is a German public company founded in 1668 with 59,077 employees.
PACBIO
PACBIO is a United States-based public company founded in 2000 with 485 employees.
DANAHER
DANAHER is a United States-based public company founded in 1969 with 59,000 employees.
BIO-RAD LABORATORIES, INC.
BIO-RAD LABORATORIES, INC. is a United States-based public company founded in 1952 with 7,450 employees.
QIAGEN
QIAGEN is a Netherlands-based public company founded in 1984 with 5,500 employees.
REVVITY
REVVITY is a United States-based public company founded in 1937 with 11,000 employees.
HOLOGIC, INC.
HOLOGIC, INC. is a United States-based private company founded in 1985 with 7,070 employees.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation data for India's epigenetics sector with verified CAGR of 14.2%, enabling accurate financial forecasting and investment decision-making for the 2025-2030 period.
- Competitive Positioning Strategy : Understand India-specific market dynamics, regional growth drivers, and competitive landscape to develop targeted go-to-market strategies and identify partnership opportunities within the Indian epigenetics ecosystem.
- Investment & Expansion Planning : Access detailed India market insights to evaluate expansion feasibility, assess market entry barriers, and identify high-growth segments within diagnostics, research, and therapeutic applications.
- Stakeholder Communication : Leverage credible market data and projections to communicate India's epigenetics opportunity to investors, board members, and stakeholders, supporting business case development and funding proposals.
- Risk Mitigation & Forecasting : Utilize comprehensive India-specific market analysis to identify growth catalysts, regulatory considerations, and potential headwinds, enabling informed strategic planning and resource allocation decisions.
Frequently asked questions
What is the current size of India's epigenetics market?
India's epigenetics market was valued at $48.9 million in 2025 and is expected to grow significantly through 2030.
What is the projected growth rate for India's epigenetics market?
India's epigenetics market is projected to grow at a compound annual growth rate of 14.2% from 2025 to 2030.
What will India's epigenetics market size be in 2030?
India's epigenetics market is forecast to reach $95.1 million by 2030, nearly doubling from 2025 levels.
What are the primary drivers of growth in India's epigenetics market?
India's market growth is driven by increasing healthcare investments, rising chronic disease prevalence, precision medicine adoption, and expanding biotechnology infrastructure.
Which therapeutic areas are leading India's epigenetics market expansion?
Oncology, cardiovascular disease, and metabolic disorders are the primary therapeutic areas driving India's epigenetics market growth.
RESEARCH METHODOLOGY
This research study extensively utilized secondary sources, directories, and databases to identify and collect valuable information for analyzing the global epigenetics market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was triangulated with inputs from primary research to determine the final market size.
Secondary Research
Secondary research was primarily used to identify and collect information for the comprehensive technical, market-oriented, and commercial study of the epigenetics market. The secondary sources used for this study include World Health Organization (WHO), World Intellectual Property Organization (WIPO), International Union of Biochemistry and Molecular Biology (IUBMB), National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI), Centers for Disease Control and Prevention (CDC), American Cancer Society (ACS), American Society for Biochemistry and Molecular Biology (ASBMB), Canadian Society for Molecular Biosciences (CSMB), National Institute of Environmental Health Sciences (NIEHS), Canadian Institutes of Health Research (CIHR), Genome Canada, and Central Drugs Standard Control Organisation (CDSCO). Academic Journals and Company Websites, corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations, among others. Secondary data were collected and analyzed to determine the overall size of the global epigenetics market, which was subsequently validated through primary research. These sources were also used to gather key information about major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technological perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market’s prospects. Various primary sources from the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.
Note: Tier 1 companies’ revenue is more than USD 10 billion; Tier 2 companies’ revenue ranges between USD 1 and 10 billion; and Tier 3 companies’ revenue ranges between USD 500 million and USD 1 billion
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The top-down and bottom-up approaches were used to estimate & validate the total size of the epigenetics market. These methods were also used extensively to estimate the size of various market segments.
Data Triangulation
After evaluating the overall market size through the market size estimation process, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from the demand and supply sides.
Market Definition
The epigenetics market is defined as the use of products such as reagents & kits, instruments and software for isolation/extraction, target enrichment, amplification/library preparation, sequencing/profiling and bioinformatics & data analysis of epigenetic biomarkers and samples (biological samples such as liquid biopsy samples, tissue samples and nucleic acid & protein isolates). The report scope is inclusive of outsourcing services such as DNA methylation services, chromatin profiling services, and single-cell/multi-omics services, among others. These products & services applied in drug discovery & development (oncology, metabolic disorders, immunology, cardiovascular diseases), and research (developmental biology) are covered in the report scope.
Key Stakeholders
- Pharmaceutical & biotechnology companies
- Contract research organizations (CROs)
- Contract development and manufacturing organizations (CDMOs)
- Life science companies
- Academic & research institutes
- Private research institutes
- Venture capitalists & investors
- Market research & consulting firms
- Government associations
- Medical institutions & universities
- Hospitals & clinics
Report Objectives
- To define, describe, and forecast the epigenetics market based on offering, product, service, technology, method, application, end user (product), end user (service), and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall epigenetics market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments concerning six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players in the epigenetics market and comprehensively analyze their core competencies and market rankings
- To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, partnerships, and collaborations in the epigenetics market
- To benchmark players within the epigenetics market using the ‘Company Evaluation Matrix’ framework, which analyzes market players based on various parameters within the broad categories of business and product/service strategy
Available customizations:
With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:
Geographical Analysis
- Further breakdown of the Rest of Europe epigenetics market, by country
- Further breakdown of the Rest of Asia Pacific epigenetics market, by country
- Further breakdown of the Rest of Latin America epigenetics market, by country
- Further breakdown of the Rest of Middle East epigenetics market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Get the Full Epigenetics Market Report
Full forecast, segment splits, and company analysis for all Epigenetics Market.
- Canada Epigenetics Market
- US Epigenetics Market
- Germany Epigenetics Market
- UK Epigenetics Market
- France Epigenetics Market
- Italy Epigenetics Market
- Spain Epigenetics Market
- China Epigenetics Market
- Japan Epigenetics Market
- Australia Epigenetics Market
- South Korea Epigenetics Market
- Brazil Epigenetics Market
- Mexico Epigenetics Market
- Saudi Arabia Epigenetics Market
- UAE Epigenetics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report